Biotech & Life Science
The latest biotechnology and life science news.
Pharmaceutical Product Development shares plunge 15%
Despite beating analysts’ expectations, life science services firm takes a financial hit after reporting quarterly drop in revenues and $200 million in contract cancellations. Company recently laid off 270 workers, sold research center in RTP.
Wyeth plant in Sanford closer to new ownership by Pfizer
Shareholders of drugmaker Wyeth on Monday voted overwhelmingly to be bought by industry giant Pfizer Inc., pushing aside one of the deal's final hurdles.
Video: 'Liver machine' can help transplant patients in need
An experimental machine is giving some patients in need of a liver transplant a chance to wait longer for the surgery they need.
UNC-Wilmington receives $15 million for marine biotech building
The National Institute of Standards and Technology announced Monday that the University of North Carolina-Wilmington would receive $15 million for a new facility for the Marine Biotechnology in North Carolina program.
Financially ailing Adherex sweeps out its top executive, six board members
Former GlaxoWellcome scientist is new chief science officer; top investor takes over as chairman, and UNC-CH graduate is new CEO. Company has warned it is short on cash for operations.
RTP and swine flu: Government moves to protect vaccine makers
Three Triangle-area companies - GlaxoSmithKline, Novartis, AlphaVax - are working on vaccines.
FDA approves Raleigh-based BioDelivery Science’s powerful painkiller
Approval triggers $12 million payment to BDSI. Product, called Onsolis, targets breakthrough cancer pain and is delivered through dissolvable patch.
